These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1050)

  • 1. [Central action of WA-335-BS, a substance with peripheral antiserotonin and antihistaminic activity].
    Kähling J; Ziegler H; Ballhause H
    Arzneimittelforschung; 1975 Nov; 25(11):1737-44. PubMed ID: 1050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1975 Nov; 25(11):1723-37. PubMed ID: 1049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The action of compound WA-335 on the central nervous system.
    Maj J; Baran L; Sowińska H; Gancarczyk L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):205-22. PubMed ID: 945051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effects of the anthracene derivative danitracen (WA335-BS) and amitriptyline in depressive patients (author's transl)].
    Matussek N; Benkert O; Fidetzis K; Flach D; Hermann HU; Kaumeier S; Kindt H; Kinzler E; Rüther E; Watzka W
    Arzneimittelforschung; 1976; 26(6):1160-2. PubMed ID: 786311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy.
    Maj J; Sowińska H; Baran L
    Arch Immunol Ther Exp (Warsz); 1976; 24(2):197-203. PubMed ID: 945050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appetite stimulant activity of 3-carboxy-10,11-dihydrocyproheptadine.
    Clineschmidt BV; Hanson HM; McGuffin JC; Lotti VJ; Scriabine A; Stone CA
    Arch Int Pharmacodyn Ther; 1976 Oct; 223(2):287-300. PubMed ID: 11758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different central effects of the 5-HT antagonists mianserine and cyproheptadine.
    van Riezen H
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):256-69. PubMed ID: 5054734
    [No Abstract]   [Full Text] [Related]  

  • 8. On the central antiserotonin action of trazodone.
    Baran L; Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1979; 31(1):25-33. PubMed ID: 482164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lack of antidepressant properties and a potent central antiserotonin activity of Org 8282.
    Przegaliński E; Baran L; Siwanowicz J; Rawłów A
    Pol J Pharmacol Pharm; 1986; 38(4):377-84. PubMed ID: 3774630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some pharmacodynamical properties of niaprazine, a new antihistaminic agent].
    Duchene-Marullaz P; Rispat G; Perriere JP; Hache J; Labrid C
    Therapie; 1971; 26(6):1203-9. PubMed ID: 4401719
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemico-pharmacological studies on saponins of Panax ginseng C. A. Meyer. II. Pharmacological part.
    Kaku T; Miyata T; Uruno T; Sako I; Kinoshita A
    Arzneimittelforschung; 1975 Apr; 25(4):539-47. PubMed ID: 239732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the central antiserotonin activity of benzoctamine and opipramol.
    Przegaliński E; Baran L; Palider W; Bigajska K
    Pol J Pharmacol Pharm; 1978; 30(6):781-90. PubMed ID: 582625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
    Mikhaĭlova TV; Terekhina AI; Gilev AP
    Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of antihistaminic drugs in tests for antidepressant action.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):321-35. PubMed ID: 6119682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].
    Chiba S; Nagawa Y; Yui T
    Nihon Yakurigaku Zasshi; 1970; 66(1):64-75. PubMed ID: 4393359
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
    Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
    Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+)- and (-)-3-Methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadine.
    Remy DC; Rittle KE; Hunt CA; Anderson PS; Engelhardt EL; Clineschmidt BV; Scriabine A
    J Med Chem; 1977 Dec; 20(12):1681-4. PubMed ID: 592336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant activities of WEB 1881, a new nootropic agent.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
    Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.